# Tvardi Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/tvardi-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 21 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-17T04:47:15.429264+00:00 |
| Last reviewed | 2026-10-17T04:47:15.429264+00:00 |

## Identity

- Legal name: Tvardi Therapeutics, Inc.
- Display name: Tvardi Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T04:47:15.429264+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.839 |
| Directors | 6 |
| Committees | 7 |
| Governance events | 17 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Cynthia Smith: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:5
- Imran Alibhai, Ph.D.: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:6
- Michael S. Wyzga: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:7
- Sujal Shah: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:8
- Susan Shiff, Ph.D.: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:9
- Wallace L. Hall, Jr.: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:10

## Committees

- Audit (audit). Chair: Michael S. Wyzga. Members: Michael S. Wyzga (chair, current); Wallace L. Hall, Jr. (member, current). committee_id=alpha:committee:tvardi-therapeutics-inc:audit
- Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Michael S. Wyzga (member, current). committee_id=alpha:committee:tvardi-therapeutics-inc:audit-chair
- Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Wallace L. Hall, Jr. (member, current). committee_id=alpha:committee:tvardi-therapeutics-inc:audit-compensation
- Compensation (compensation). Chair: Sujal Shah. Members: Sujal Shah (chair, current); Wallace L. Hall, Jr. (member, current). committee_id=alpha:committee:tvardi-therapeutics-inc:compensation
- Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Sujal Shah (member, current). committee_id=alpha:committee:tvardi-therapeutics-inc:compensation-chair
- Nominating and Governance (nominating_governance). Chair: Cynthia Smith. Members: Cynthia Smith (chair, current). committee_id=alpha:committee:tvardi-therapeutics-inc:nominating-and-governance
- Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Cynthia Smith (member, current). committee_id=alpha:committee:tvardi-therapeutics-inc:nominating-and-governance-chair

## Executive leadership

- Dan Conn, J.D., M.B.A.: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:11
- Imran Alibhai, Ph.D.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:12
- John Kauh, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:13

## Governance events

- CFO_CHANGED: Dan Conn, J.D., M.B.A. executive of Tvardi Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1fj8i1t1w968hb
- CEO_CHANGED: Imran Alibhai, Ph.D. executive of Tvardi Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:u7tbr9iqqdax
- EXECUTIVE_APPOINTED: John Kauh, M.D. executive of Tvardi Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:xed3te1x98wkk
- DIRECTOR_APPOINTED: Cynthia Smith seat on Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:16lx2yhsx7gpr
- DIRECTOR_APPOINTED: Imran Alibhai, Ph.D. seat on Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1r6fz8ze6qh4
- DIRECTOR_APPOINTED: Michael S. Wyzga seat on Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:frnipv176nz0l
- DIRECTOR_APPOINTED: Sujal Shah seat on Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1q0zc461ppwcjy
- DIRECTOR_APPOINTED: Susan Shiff, Ph.D. seat on Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:2shl9h98rqu3
- DIRECTOR_APPOINTED: Wallace L. Hall, Jr. seat on Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1jzqa7jefvqtr
- COMMITTEE_CREATED: Audit · Chair committee of Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1lse33jnr9srx
- COMMITTEE_MEMBER_ADDED: Michael S. Wyzga member of Audit · Chair, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:126g86is21m9w
- COMMITTEE_CREATED: Audit; Compensation committee of Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1gd5iebugvlzj
- COMMITTEE_MEMBER_ADDED: Wallace L. Hall, Jr. member of Audit; Compensation, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:bpsijp1v4pjj3
- COMMITTEE_CREATED: Compensation · Chair committee of Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1nqgoj2blrwqu
- COMMITTEE_MEMBER_ADDED: Sujal Shah member of Compensation · Chair, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:6vgg72z9yy6
- COMMITTEE_CREATED: Nominating and Governance · Chair committee of Tvardi Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:1pr9k2d1k9ycvb
- COMMITTEE_MEMBER_ADDED: Cynthia Smith member of Nominating and Governance · Chair, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:47:15.429264+00:00. event_id=alpha:event:transition:xet330y52r0c

## Scoped resources

- `alpha://company/tvardi-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record
- `alpha://company/tvardi-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=identity
- `alpha://company/tvardi-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/tvardi-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=board
- `alpha://company/tvardi-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=committees
- `alpha://company/tvardi-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=leadership
- `alpha://company/tvardi-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=ownership
- `alpha://company/tvardi-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=financials
- `alpha://company/tvardi-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/tvardi-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=compensation
- `alpha://company/tvardi-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=governance
- `alpha://company/tvardi-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/tvardi-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=audit
- `alpha://company/tvardi-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=legal
- `alpha://company/tvardi-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=risk
- `alpha://company/tvardi-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=cyber
- `alpha://company/tvardi-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/tvardi-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=agents
- `alpha://company/tvardi-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/tvardi-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=events
- `alpha://company/tvardi-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=relationships
- `alpha://company/tvardi-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=assessments
- `alpha://company/tvardi-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:michael-s-wyzga","name":"Michael S. Wyzga"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:wallace-l-hall-jr","name":"Wallace L. Hall, Jr."},"source_id":"board_seats"}`
- Claim alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:sujal-shah","name":"Sujal Shah"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:wallace-l-hall-jr","name":"Wallace L. Hall, Jr."},"source_id":"board_seats"}`
- Claim alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"source_id":"board_seats"}`

## Leadership

- Cynthia Smith: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003.
- Imran Alibhai, Ph.D.: Director. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003.
- Michael S. Wyzga: Director, Audit · Chair. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003.
- Sujal Shah: Director, Compensation · Chair. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003.
- Susan Shiff, Ph.D.: Director. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003.
- Wallace L. Hall, Jr.: Director, Audit; Compensation. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003.
- Dan Conn, J.D., M.B.A.: Chief Financial Officer. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:11. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a3be88b5fda3feda2f2c9ae40f045f30f4356a209fc3c546dee8bb94cfada7d3.
- Imran Alibhai, Ph.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:12. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f12493987f012e34ae11cd13d135857314e7d4f516ec7cc1c8f65a153d3d9900.
- John Kauh, M.D.: Chief Medical Officer. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:leadership_role:13. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f702ccbe4cb1393128ecdc54cfb32376782fb1f30af57929af598665f13a5b3b.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Michael S. Wyzga; Members Michael S. Wyzga (Chair); Wallace L. Hall, Jr.. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.
- Compensation: Chair Sujal Shah; Members Sujal Shah (Chair); Wallace L. Hall, Jr.. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.
- Nominating and Governance: Chair Cynthia Smith; Members Cynthia Smith (Chair). Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Tvardi Therapeutics, Inc.. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bbe30e574bd05e12d7d0004ce6f179cd6584bbdb0dea52129f8a7356358eb25.

## Entity Status

- Public listing published. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bbe30e574bd05e12d7d0004ce6f179cd6584bbdb0dea52129f8a7356358eb25.

## Published Fact

- US. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bbe30e574bd05e12d7d0004ce6f179cd6584bbdb0dea52129f8a7356358eb25.

## Committee Appointment

- Michael S. Wyzga: chair, Audit. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.
- Wallace L. Hall, Jr.: member, Audit. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.
- Sujal Shah: chair, Compensation. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.
- Wallace L. Hall, Jr.: member, Compensation. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.
- Cynthia Smith: chair, Nominating and Governance. Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf.

## Security Listing

- TVRD (NASDAQ). Claim: alpha:claim:company:8284ee8e-2aa1-45b0-ac58-3d76023f7603:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4bbe30e574bd05e12d7d0004ce6f179cd6584bbdb0dea52129f8a7356358eb25.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:4bbe30e574bd05e12d7d0004ce6f179cd6584bbdb0dea52129f8a7356358eb25: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/tvardi-therapeutics-inc).
- alpha:projection-evidence:document:6c81bfe4af0174d03292a7890551a9d8b90f766b9ece57720ea4aeed3c246003: [Tvardi Therapeutics, Inc. DEF 14A 2026-04-23](https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm).
- alpha:projection-evidence:document:a3be88b5fda3feda2f2c9ae40f045f30f4356a209fc3c546dee8bb94cfada7d3: [TVRD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm).
- alpha:projection-evidence:document:f12493987f012e34ae11cd13d135857314e7d4f516ec7cc1c8f65a153d3d9900: [TVRD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm).
- alpha:projection-evidence:document:f702ccbe4cb1393128ecdc54cfb32376782fb1f30af57929af598665f13a5b3b: [TVRD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm).
- alpha:projection-evidence:03e37199347a641e01211612cd6672100c83aa615de7c781e844abd2f2f078cf: [Audit](https://www.sec.gov/Archives/edgar/data/1346830/000110465926047695/tvrd-20260609xdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/tvardi-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/tvardi-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/tvardi-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/tvardi-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-10-17T07:00:40.040741+00:00; recorded 2026-10-17T07:00:40.040741+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.